EU AI Act: the 2 August 2026 deadline is being postponed to December 2027
What changes, what already applies, and what it means for healthcare, finance and SMEs across the EU/UK?
On 16 June 2026 the European Parliament adopted the Digital Omnibus on AI (423 in favour, 57 against, 174 abstentions). The Council still has to formally adopt the text (expected late June), after which publication in the Official Journal follows. Until that publication the postponement is not legally binding and 2 August 2026 remains the formally applicable date — count on the new dates, but be prepared.
Is the EU AI Act deadline of 2 August 2026 going ahead?
No — not for the heaviest obligations. With the Digital Omnibus on AI, the European Council and Parliament have agreed to postpone the high-risk obligations: stand-alone systems (Annex III) from 2 August 2026 to 2 December 2027, and systems embedded in products (Annex I) from 2 August 2027 to 2 August 2028. One important nuance: as long as that amendment is not published in the EU Official Journal, 2 August 2026 remains the formally applicable date. And a number of obligations do not change — those have applied since 2025.
What happened
The roll-out of the high-risk rules was visibly behind schedule at the end of 2025; standards and guidance were not ready. In response, the European Commission tabled the Digital Omnibus on AI on 19 November 2025. The sequence since:
- 26 March 2026 — the European Parliament adopts its negotiating position (569 in favour, 45 against, 23 abstentions).
- 7 May 2026 — Council and Parliament reach a provisional political agreement; member states (Coreper) confirm on 13 May.
- 2 June 2026 — the IMCO and LIBE committees give the green light.
- 16 June 2026 — Parliament adopts the final text: 423 in favour, 57 against, 174 abstentions.
- Next — formal adoption by the Council (expected late June), publication in the Official Journal, entry into force three days later. The legislators want this done before 2 August 2026.
Practical consequence: until the amendment is in the Official Journal, the original date is still legally leading. Prepare as if both scenarios could happen — but count on the new dates.
What is being postponed (and what is added)
| Obligation | Old date | New date |
|---|---|---|
| High-risk — Annex III (biometrics, critical infrastructure, education, work/HR, essential services, law enforcement, migration, justice) | 2 Aug 2026 | 2 Dec 2027 |
| High-risk — embedded in regulated products (Annex I, e.g. medical devices, machinery) | 2 Aug 2027 | 2 Aug 2028 |
| Watermarking of synthetic/AI content (Art. 50(2)) | 2 Aug 2026 | 2 Dec 2026 |
| National AI sandbox (Art. 57) | 2 Aug 2026 | 2 Aug 2027 |
| New ban: AI 'nudify'/non-consensual imagery + CSAM (Art. 5) | — | 2 Dec 2026 |
Note: the package is not pure deregulation. A new ban is added to Article 5 — on AI that generates non-consensual intimate imagery ('nudify') or child sexual abuse material.
What does NOT change — and this is often missed
These obligations already applied and remain in force:
- Prohibited AI practices (Art. 5) — in force since 2 February 2025. Think of certain forms of social scoring, untargeted scraping of facial images, emotion recognition in the workplace.
- AI-literacy obligation (Art. 4) — since 2 February 2025. Anyone who has staff working with AI must ensure they have sufficient AI knowledge.
- GPAI models (general-purpose AI) — obligations since 2 August 2025.
- General transparency (Art. 50) — stays 2 August 2026 (only the watermarking sub-obligation moves to December 2026).
- Enforcement and penalty regime — national authorities get their enforcement teeth from 2 August 2026, including for the prohibited practices that have applied since 2025.
In other words: the postponement affects the high-risk build burden, not the basic rules. Those are here now.
The fines (unchanged)
The penalty regime (Art. 99) stays as it is:
- Prohibited practices: up to €35 million or 7% of worldwide annual turnover — whichever is higher.
- Other obligations, including high-risk: up to €15 million or 3%.
- Incorrect/misleading information to authorities: up to €7.5 million or 1%.
- For SMEs and start-ups, the lower of the two amounts always applies.
What it means for healthcare
Clinical AI usually becomes high-risk via the medical-device route (Art. 6(1)), not via the use-case list. According to the official guidance MDCG 2025-6, an AI device is high-risk if two conditions are met together: (1) it is itself a medical device or a safety component of one, and (2) it requires a conformity assessment by a notified body under the MDR/IVDR.
- In practice almost all clinically meaningful AI software falls under MDR class IIa or higher (Rule 11) or IVDR class B+ — so high-risk. Examples: clinical decision support (CDSS), image/ECG/pathology analysis, treatment recommendation, early-warning scoring.
- In-house exception: devices built and used within a single healthcare institution (Art. 5(5) MDR/IVDR) are not high-risk AI — relevant for academic hospitals building their own models. But the Art. 5 ban, Art. 50 transparency and GDPR still apply.
- Emergency triage falls separately under Annex III (point 5(d)) and is high-risk in its own right.
The product-bound route moves to 2 August 2028 — extra room for medical-AI builders. But the MDR/IVDR, GDPR and health-security (e.g. NEN 7510) requirements continue to apply in full; a DPIA is generally required for health data.
What it means for finance
Two use cases are explicitly high-risk (Annex III, point 5):
- Creditworthiness / credit scoring of natural persons (point 5(b)) — with an exception for fraud detection.
- Risk assessment and pricing of life and health insurance (point 5(c)).
Three things to know:
- The 'no significant risk' exception (Art. 6(3)) rarely helps here: profiling of natural persons is always high-risk.
- A Fundamental Rights Impact Assessment (Art. 27) is mandatory — including for private banks and insurers — for 5(b) and 5(c). That duty does not fall on most other private parties.
- DORA (since 17 January 2025) runs in parallel and is not postponed: for a high-risk credit AI, AI Act and DORA obligations stack (ICT risk, resilience, third-party oversight).
The use-case route moves to 2 December 2027.
National implementation (example: the Netherlands)
Each member state designates its own authorities and implementation. As one example, the Dutch government published a draft Implementation Act on 20 April 2026 (consultation ran to 1 June 2026; not yet adopted). The gist:
- The Data Protection Authority (AP) and the Radiocommunications Agency (RDI) take a coordinating role; the RDI becomes the national single point of contact (SPOC, Art. 70).
- Beneath them, sector regulators supervise — for health the IGJ, for finance the AFM and DNB.
- The GDPR line and the AI Act line run together: for health data, the AP tests security in practice against the NEN 7510 standard.
What you should do now — despite the postponement
A delay is not a cancellation. The extra ~16 months are exactly enough to build high-risk systems properly, rather than sprinting to a date that moved anyway. Four things already in play:
- 01AI literacy (Art. 4) is already mandatory. Train the people working with AI — it's low-hanging fruit and it applies now.
- 02Check for prohibited practices (Art. 5). Don't run anything that's already banned; enforcement starts 2 August 2026.
- 03Inventory and classify your AI systems. Which will fall under high-risk (Annex III or the product route)? Without that map you can't plan.
- 04Build governance from the design, not as a compliance layer afterwards: audit trails, confidence-scoring per step, human-in-the-loop on decisions that matter, logging (Art. 12, with at least six months' retention for deployers) and a DPIA where personal data is involved.
That last point is exactly how I build systems: safety and human control sit in the design, not around it. Then "being compliant" isn't a separate project, but a property of the system.
Unsure whether a planned or existing AI use case will fall under high-risk — and what that means concretely for your healthcare or finance organisation? In a Discovery I map that in 2–4 weeks, including an honest "no AI here" list.
Frequently asked questions.
Is the EU AI Act deadline of 2 August 2026 still going ahead?
For the heaviest, high-risk obligations, no. On 16 June 2026 the European Parliament adopted the Digital Omnibus on AI, postponing high-risk to 2 December 2027 (Annex III) and 2 August 2028 (Annex I, product-bound). The Council still has to formally adopt the text and publication in the Official Journal follows; until that moment, 2 August 2026 remains the formally applicable date.
Which EU AI Act rules already apply?
The prohibited AI practices (Art. 5) and the AI-literacy obligation (Art. 4) have applied since 2 February 2025; the rules for general-purpose AI since 2 August 2025. Enforcement by national authorities starts 2 August 2026.
How high are the fines under the EU AI Act?
Up to €35 million or 7% of worldwide annual turnover for prohibited practices; up to €15 million or 3% for other obligations, including high-risk; up to €7.5 million or 1% for incorrect information. For SMEs, the lower of the two amounts applies.
When is clinical AI a high-risk AI system?
When it is a medical device or safety component that requires a notified-body assessment under the MDR/IVDR — in practice MDR class IIa+ or IVDR class B+. The product-bound obligations apply from 2 August 2028.
Who supervises the EU AI Act (in the Netherlands)?
Each member state designates its own authorities. In the Netherlands the Data Protection Authority (AP) and the Radiocommunications Agency (RDI) take a coordinating role, with sector regulators such as the IGJ (health), AFM and DNB (finance).